Bromfenac is a nonsteroidal anti-inflammatory drug (NSAID) for ophthalmic use. Ophthalmic NSAIDs are becoming a cornerstone for the management of ocular pain and inflammation. Their well-characterized anti-inflammatory activity, analgesic property, and established safety record have also made NSAIDs an important tool for optimizing surgical outcomes. Non-ophthalmic formulations of bromfenac were withdrawn in the US in 1998 due to cases of severe liver toxicity.[L43942,T239]
Synonyms
2-amino-3-(4-bromobenzoyl)benzeneacetic acid
Bromfenac sodium
Bromfenacum
Bromfenac
Bromfenaco
[2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid
Brand Names
Bromsite 0.075%
Pred-Brom
Pred Phos - Brom
Prolensa
Xibrom
Bromfenac 0.075%
Bromfenac Ophthalmic Solution, 0.09%
Apo-bromfenac
Bromfenac Ophthalmic Solution
Yellox
Bromfenac Sodium
Auro-bromfenac
Bromfenac
Bromfenac Ophthalmic Solution, 0.07%
Bromday
Bromfenac Ophthalmic Solution 0.09%
Pred-Gati-Brom
Eugia-bromfenac
Pred Phos-Gati-Brom
Indication
For the treatment of postoperative inflammation in patients who have undergone cataract extraction.
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682